Gary Goza, MD
Sleep Medicine · Little Rock, ARNPI 1669430252
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Jazz Pharmaceuticals Inc. accounts for 62.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $820 and has fallen 97.7% since, to $19 in 2025.
Across 131 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$2K
- Harmony Biosciences LLC$416
- Axsome Therapeutics, Inc.$345
- Merck$130
- Inspire Medical Systems, Inc.$126
- Avadel CNS Pharmaceuticals, LLC$40
- plus $70 from 3 others
What the payments were for
- Food & beverage$2,84394%
- Education$1906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 84 | $1,905 |
| Harmony Biosciences LLC | 14 | $416 |
| Axsome Therapeutics, Inc. | 14 | $345 |
| Merck | 7 | $130 |
| Inspire Medical Systems, Inc. | 6 | $126 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Eisai Inc. | 1 | $17 |
| ZOLL Respicardia, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sleep medicine providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 12 | $230,598 |
| BelsomraSuvorexant | 14 | $7,466 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 164 | $6,597 |
| Methylphenidate Hcl | 58 | $2,819 |
| Dextroamphetamine Sulfate | 13 | $2,815 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 55 | $2,659 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $1,670 |
| Modafinil | 21 | $1,359 |
| Armodafinil | 14 | $1,044 |
| Doxepin Hcl | 13 | $354 |
| Gabapentin | 22 | $289 |
| Ropinirole Hcl | 11 | $223 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $158 |
| Tizanidine Hcl | 12 | $140 |
| Zolpidem Tartrate | 16 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $130 | $7,46614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few sleep medicine providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other sleep medicine in Little Rock
- Jason WilliamsLittle Rock$5K
- David DavilaLittle Rock$5K
- Erin CreightonLittle Rock$4K
- Khaled KhasawnehLittle Rock$621
- Nanjunda PrabhaBatesville$4K
- Julie AllenSearcy$4K
- Dimitry FominRogers$4K
- Erica WilliamsSearcy$2K
- Michael EcklesFayetteville$2K
- David AndersonConway$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.